Targeted Drug May Lower Odds for Breast Cancer's Return in Some Patients
A new clinical trial shows adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Health | Hormonal Therapy | Hormones | Women